Annual EBIT
-$378.94M$143.34M-60.84%
Summary
- Current Value
- As of today, RNA annual EBIT is -$378.94M, down -60.84% on
- Historical Performance
- RNA annual EBIT is down -220.99% over the past 3 years, and down -2084.45% over the past 5 years
- All-Time High Comparison
- RNA annual EBIT is currently -3509.60% below its historical high of -$10.50M set on
- 3-Year Low Comparison
- RNA annual EBIT is at its 3-year low
- Sector Comparison
- RNA annual EBIT is higher than 3.47% of companies in Healthcare sector
EBIT Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBIT | -$378.94M | -60.8% | -221.0% | -2084.4% | -3509.6% | |
| Quarterly EBIT | -$188.81M | -92.4% | -320.2% | -1546.7% | -8584.7% | |
| TTM EBIT | -$612.46M | -88.6% | -272.9% | -1699.7% | -10000.0% | |
| Price | $72.37 | +141.8% | +264.9% | +157.1% | – | |
| PE Ratio | - | – | – | – | – | |
| Annual Revenue | $10.90M | +14.0% | +16.9% | +369.9% | +2775.2% | |
| Annual EPS | -$2.89 | +0.6% | -1.4% | -338.1% | -866.0% | |
| Annual EBITDA | -$376.16M | -61.1% | -220.4% | -2112.8% | -3618.8% | |
| Annual Net Income | -$322.30M | -51.9% | -173.1% | -1203.1% | -2773.6% |
EBIT Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | -$178.91M | N/A | -111.8% |
| 5Y | -$44.15M | N/A | -758.4% |
| All | -$10.50M | -3509.6% |
EBIT Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | -$378.94M | at low | |
| 5Y | -$378.94M | at low | |
| All | -$378.94M | at low |
EBIT History
| Year | Value | Change |
|---|---|---|
| -$378.94M | -60.8% | |
| -$235.60M | -31.7% | |
| -$178.91M | -51.6% | |
| -$118.05M | -167.4% |
| Year | Value | Change |
|---|---|---|
| -$44.15M | -154.5% | |
| -$17.35M | -65.2% | |
| -$10.50M | - |
FAQ
What is the current annual EBIT of RNA?
As of today, RNA annual EBIT is -$378.94M
What is 1-year change in RNA annual EBIT?
RNA annual EBIT is down -60.84% year-over-year
What is 3-year change in RNA annual EBIT?
RNA annual EBIT is down -220.99% over the past 3 years
How far is RNA annual EBIT from its all-time high?
RNA annual EBIT is currently -3509.60% below its historical high of -$10.50M set on December 31, 2018
How does RNA annual EBIT rank versus sector peers?
RNA annual EBIT is higher than 3.47% of companies in Healthcare sector
When is RNA next annual earnings release?
The next annual earnings release for RNA is on
Quarterly EBIT
-$188.81M$17.66M-10.32%
Summary
- Current Value
- As of today, RNA quarterly EBIT is -$188.81M, down -10.32% on
- Historical Performance
- RNA quarterly EBIT is down -92.40% year-over-year, and down -320.23% over the past 3 years
- All-Time High Comparison
- RNA quarterly EBIT is currently -8584.73% below its historical high of -$2.17M set on
- 3-Year Low Comparison
- RNA quarterly EBIT is at its 3-year low
- Sector Comparison
- RNA quarterly EBIT is higher than 0.80% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBIT | -$188.81M | -10.3% | -92.4% | -320.2% | -1546.7% | |
| Annual EBIT | -$378.94M | – | -60.8% | -221.0% | -2084.4% | |
| TTM EBIT | -$612.46M | -17.4% | -88.6% | -272.9% | -1699.7% | |
| Price | $72.37 | +50.0% | +141.8% | +264.9% | +157.1% | |
| PE Ratio | - | – | – | – | – | |
| Quarterly Revenue | $12.48M | +224.3% | +434.0% | +402.6% | +614.5% | |
| Quarterly EPS | -$1.27 | -4.2% | -94.1% | -54.0% | -313.8% | |
| Quarterly EBITDA | -$187.75M | -10.2% | -92.7% | -321.6% | -1552.0% | |
| Quarterly Net Income | -$174.44M | -10.9% | -117.0% | -300.1% | -1425.0% |
Quarterly EBIT Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$120.99M | N/A | -56.0% |
| 3Y | -$52.63M | -258.7% | |
| 5Y | -$16.29M | N/A | -1058.8% |
| All | -$2.17M | -8584.7% |
Quarterly EBIT Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$188.81M | at low | |
| 3Y | -$188.81M | at low | |
| 5Y | -$188.81M | at low | |
| All | -$188.81M | at low |
Quarterly EBIT History
FAQ
What is the current quarterly EBIT of RNA?
As of today, RNA quarterly EBIT is -$188.81M
What is RNA quarterly EBIT most recent change?
RNA quarterly EBIT was down -10.32% on September 30, 2025
What is 1-year change in RNA quarterly EBIT?
RNA quarterly EBIT is down -92.40% year-over-year
How far is RNA quarterly EBIT from its all-time high?
RNA quarterly EBIT is currently -8584.73% below its historical high of -$2.17M set on March 31, 2019
How does RNA quarterly EBIT rank versus sector peers?
RNA quarterly EBIT is higher than 0.80% of companies in Healthcare sector
When is RNA next earnings release?
The next earnings release for RNA is on
TTM EBIT
-$612.46M$90.67M-17.38%
Summary
- Current Value
- As of today, RNA TTM EBIT is -$612.46M, down -17.38% on
- Historical Performance
- RNA TTM EBIT is down -88.63% year-over-year, and down -272.91% over the past 3 years
- All-Time High Comparison
- RNA TTM EBIT is currently -28071.80% below its historical high of -$2.17M set on
- 3-Year Low Comparison
- RNA TTM EBIT is at its 3-year low
- Sector Comparison
- RNA TTM EBIT is higher than 1.07% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBIT | -$612.46M | -17.4% | -88.6% | -272.9% | -1699.7% | |
| Annual EBIT | -$378.94M | – | -60.8% | -221.0% | -2084.4% | |
| Quarterly EBIT | -$188.81M | -10.3% | -92.4% | -320.2% | -1546.7% | |
| Price | $72.37 | +50.0% | +141.8% | +264.9% | +157.1% | |
| PE Ratio | - | – | – | – | – | |
| TTM Revenue | $20.87M | +94.5% | +106.3% | +151.2% | +242.7% | |
| TTM EPS | -$4.17 | -17.2% | -43.9% | -27.8% | -306.3% | |
| TTM EBITDA | -$609.06M | -17.4% | -89.1% | -273.6% | -1721.3% | |
| TTM Net Income | -$549.79M | -20.6% | -96.0% | -239.2% | -1328.7% |
TTM EBIT Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$378.94M | N/A | -61.6% |
| 3Y | -$178.91M | N/A | -242.3% |
| 5Y | -$44.28M | N/A | -1283.2% |
| All | -$2.17M | >-9999.0% |
TTM EBIT Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$612.46M | at low | |
| 3Y | -$612.46M | at low | |
| 5Y | -$612.46M | at low | |
| All | -$612.46M | at low |
TTM EBIT History
FAQ
What is the current TTM EBIT of RNA?
As of today, RNA TTM EBIT is -$612.46M
What is RNA TTM EBIT most recent change?
RNA TTM EBIT was down -17.38% on September 30, 2025
What is 1-year change in RNA TTM EBIT?
RNA TTM EBIT is down -88.63% year-over-year
How far is RNA TTM EBIT from its all-time high?
RNA TTM EBIT is currently -28071.80% below its historical high of -$2.17M set on March 31, 2019
How does RNA TTM EBIT rank versus sector peers?
RNA TTM EBIT is higher than 1.07% of companies in Healthcare sector
When is RNA next earnings release?
The next earnings release for RNA is on
EBIT Formula
EBIT = Revenue − −
Data Sources & References
- RNA Official Website www.aviditybiosciences.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1599901/000159990125000210/0001599901-25-000210-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1599901/000159990125000059/0001599901-25-000059-index.htm
- RNA Profile on Yahoo Finance finance.yahoo.com/quote/RNA
- RNA Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/rna